Clinical Trial Update: A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84) [Phase 3]

View source ↗

Summary

This entry describes an ongoing Phase 3 clinical trial evaluating pembrolizumab in combination with berahyaluronidase alfa (MK-3475A) for newly diagnosed metast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Berahyaluronidase Alfa (berahyaluronidase alfa)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Lung Cancer, Non-Small Cell Lung Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING